Trial Profile
Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP STUDY)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Caffeine citrate (Primary) ; Ibuprofen (Primary) ; Ketorolac (Primary)
- Indications Retinopathy of prematurity
- Focus Therapeutic Use
- Acronyms SPIPROP study
- 29 Oct 2018 Status changed from active, no longer recruiting to completed.
- 20 Jul 2018 Planned primary completion date changed from 30 Jun 2018 to 30 Sep 2018.
- 09 Jul 2018 Status changed from recruiting to active, no longer recruiting.